- Home
- LUNG vs ISPR Comparison
LUNG vs ISPR Comparison
Compare LUNG & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- ISPR
- Stock Information
- Founded
- LUNG 1995
- ISPR 2019
- Country
- LUNG United States
- ISPR United States
- Employees
- LUNG N/A
- ISPR N/A
- Industry
- LUNG Industrial Specialties
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- LUNG Health Care
- ISPR Health Care
- Exchange
- LUNG Nasdaq
- ISPR Nasdaq
- Market Cap
- LUNG 299.3M
- ISPR 275.7M
- IPO Year
- LUNG 2020
- ISPR 2023
- Fundamental
- Price
- LUNG $7.85
- ISPR $3.33
- Analyst Decision
- LUNG Strong Buy
- ISPR Strong Buy
- Analyst Count
- LUNG 7
- ISPR 1
- Target Price
- LUNG $12.64
- ISPR $12.50
- AVG Volume (30 Days)
- LUNG 464.2K
- ISPR 45.2K
- Earning Date
- LUNG 04-30-2025
- ISPR 05-13-2025
- Dividend Yield
- LUNG N/A
- ISPR N/A
- EPS Growth
- LUNG N/A
- ISPR N/A
- EPS
- LUNG N/A
- ISPR N/A
- Revenue
- LUNG $83,789,000.00
- ISPR $148,524,656.00
- Revenue This Year
- LUNG $17.96
- ISPR $6.22
- Revenue Next Year
- LUNG $18.35
- ISPR $36.16
- P/E Ratio
- LUNG N/A
- ISPR N/A
- Revenue Growth
- LUNG 22.01
- ISPR 5.10
- 52 Week Low
- LUNG $5.46
- ISPR $2.89
- 52 Week High
- LUNG $10.01
- ISPR $9.76
- Technical
- Relative Strength Index (RSI)
- LUNG 52.84
- ISPR 27.45
- Support Level
- LUNG $7.65
- ISPR $2.89
- Resistance Level
- LUNG $8.12
- ISPR $4.08
- Average True Range (ATR)
- LUNG 0.56
- ISPR 0.32
- MACD
- LUNG -0.06
- ISPR -0.10
- Stochastic Oscillator
- LUNG 46.86
- ISPR 24.35
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.